Ophthalmic Business News

In the first part of a 12-part series, Peter J. Polack, MD, FACS, explains how evidence-based marketing can help ophthalmologists.

In the last 12 months, there has been a plethora of factors that have inched up the consumer price index, the key gauge the Federal Reserve uses as a barometer of inflation.

CorneaGen issued product recalls for certain corneal and scleral patch grafts, according to press releases from the FDA.

In this episode, Arthur Benjamin, MD, discusses dry eye treatment and trends, the challenges dry eye patients and the eye care professionals treating them and more.

Rumors swirled around the exhibit floor and coursed through gatherings of dry eye disease docs who attended the American Society of Cataract and Refractive Surgery meeting.

Kala Pharmaceuticals has entered into a definitive agreement to sell its commercial portfolio and related assets to Alcon, including Eysuvis and Inveltys.

U.S. Surgeon General Vivek H. Murthy, MD, MBA, issued an advisory addressing the alarming rate of burnout among health care workers.

Let’s take a break from the dry eye disease market for a moment, shall we?

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress here, Terry Dagnon, chief operations officer for Outlook Therapeutics, discusses the latest update on ONS-5010 for the treatment of wet AMD.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Mina Sooch, founder and CEO of Ocuphire Pharma, updates the latest research in the development of APX3330 oral tablet to treat retinal disease.